Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Lidocaine,Hyaluronic Acid
Therapeutic Area : Dermatology
Study Phase : Approved
Sponsor : Crescita Therapeutics
Deal Size : Undisclosed
Deal Type : Agreement
Crescita Signs Exclusive Distribution Agreement with FILLMED
Details : The partnership with FILLMED will allow Crescita to expand its product offering in the medical aesthetic field with the addition of the hyaluronic acid ART-Filler® injectables range and NCTF® 135 HA.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Undisclosed
January 20, 2020
Lead Product(s) : Lidocaine,Hyaluronic Acid
Therapeutic Area : Dermatology
Highest Development Status : Approved
Sponsor : Crescita Therapeutics
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?